Seladelpar

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Primary Biliary Cholangitis.

Primary Biliary Cholangitis.

Journal: Clinics in liver disease

Published: July 22, 2026

A Review of Therapies for Primary Biliary Cholangitis.

A Review of Therapies for Primary Biliary Cholangitis.

Journal: Gastroenterology & hepatology

Published: July 02, 2026

Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies.

Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies.

Journal: Cells

Published: June 25, 2026

Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review.

Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: June 19, 2026

Selective Pharmacological Activation of PPARα/δ/γ Alters the Triglyceride Composition of Fatty Liver in a Diet-Induced MASLD Mouse Model.

Selective Pharmacological Activation of PPARα/δ/γ Alters the Triglyceride Composition of Fatty Liver in a Diet-Induced MASLD Mouse Model.

Journal: Biomolecules

Published: June 15, 2026

Stable simulations do not guarantee functional engagement: a case study of off-target prediction for Seladelpar and Zanamivir.

Stable simulations do not guarantee functional engagement: a case study of off-target prediction for Seladelpar and Zanamivir.

Journal: Journal of computer-aided molecular design

Published: June 01, 2026

Crystal structure of seladelpar, C21H23F3O5S, from synchrotron powder diffraction data and density functional theory.

Crystal structure of seladelpar, C21H23F3O5S, from synchrotron powder diffraction data and density functional theory.

Journal: Acta crystallographica. Section E, Crystallographic communications

Published: May 27, 2026

Primary biliary cholangitis: current insights and novel therapies.

Primary biliary cholangitis: current insights and novel therapies.

Journal: Expert review of clinical immunology

Published: May 10, 2026

Efficacy, symptoms, and safety of second-line PBC therapies: a network meta-analysis.

Efficacy, symptoms, and safety of second-line PBC therapies: a network meta-analysis.

Journal: Frontiers in pharmacology

Published: April 18, 2026

Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis.

Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis.

Journal: Journal of comparative effectiveness research

Published: April 17, 2026

AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update.

AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 16, 2026

From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis.

From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis.

Journal: European journal of internal medicine

Published: February 28, 2026

Showing 1-12 of 109

Last Updated: 09/19/2026